We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04969861
Brief Title: BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)

First Submitted : July 9, 2021
First Submitted that Met QC Criteria : July 9, 2021
First Posted : July 21, 2021

Last Update Submitted that Met QC Criteria : May 26, 2022
Last Update Posted : June 1, 2022